Explore the diverse range of health economic applications.
The cost effectiveness of orthopaedic surgery has long been established for many procedures such as hip and knee replacements. However, navigating through various competing suppliers, alloy combinations and cup and stem sizes, can be a difficult task when investing in your health care system.
We have used national and international data and literature to establish cost-effectiveness models stratified by a number of aspects including supplier, alloy combination, prosthesis size and age, BMI and ethnicity of recipient.
With an aging population across several OECD countries, the prevalence and social and economic impact of glaucoma is expected to increase in the coming years. Glaucoma is primarily managed with prescription eye drops; however, today’s advanced technologies and procedures make it possible to diagnose and successfully manage this progressive disease.
We have used national and international literature to establish cost-effectiveness models for new and novel technologies in the ophthalmologic space.
Laboratory tests are used to obtain information about the health of a patient to make informed decisions regarding diagnosis, treatment and prevention of disease. Accuracy of laboratory tests is dictated by sensitivity and specificity.
We have experience in modelling the cost-effectiveness of laboratory tests (varying sensitivity and/or specificity) and their downstream impacts on the patient and on the health care system (over- and under- treatment and diagnosis).
Radiology is the science behind medical imaging and includes computer tomography, ultrasound and magnetic resonance imaging. To utilise such technology requires training and an ability to interpret outputs (medical images).
We have experience in modelling the cost effectiveness of radiology based technology and how it varies according to utilisation, training and accuracy in interpretation of outputs.
Surgical systems often have a large upfront capital investment and high variable costs. One advantage however, is that they can be used for many procedures, ultimately increasing their per case efficiency. These systems tend to have better outcomes for patient and the health care system with improved health outcomes, reduced chance of complication, shorter length of stay and quicker recovery.
We have looked at surgical systems and how their cost-effectiveness varies depending on utilisation.
Incorporating health economic principles and methodology into clinical trial protocol is essential when undertaking health technology assessments in the future.
We have experience in designing health economic component that fit into Phase 2 and Phase 3 clinical trials.
Being able to meet the demands for various health professions (doctors, nurses, pharmacists etc) is an important goal for any health care system.
We have modelled student and professional pipelines that feed into various health professionals, exploring demand and supply avenues with the intent of predicting potential shortages in the health care system.
Being able to identify investment opportunities within health care has economic and societal benefits that have the potential to generate and support economic development and improved access and health outcomes for patients.
We have conducted modelling that identifies the impact of timing, geography and scale of different investment opportunities in health care.